GÖKSEL, S. Et Al. 2022. Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma. NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.10 , 1077-1083.

GÖKSEL, S., İLKKILIÇ, K., Bulbul, O., & AKDOĞAN, E., (2022). Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma. NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.10, 1077-1083.

GÖKSEL, SİBEL Et Al. "Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma," NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.10, 1077-1083, 2022

GÖKSEL, SİBEL Et Al. "Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma." NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.10, pp.1077-1083, 2022

GÖKSEL, S. Et Al. (2022) . "Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma." NUCLEAR MEDICINE COMMUNICATIONS , vol.43, no.10, pp.1077-1083.

@article{article, author={SİBEL GÖKSEL Et Al. }, title={Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2022, pages={1077-1083} }